TheProfitWatch

FBLG - FibroBiologics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.31 0.02 (6.91%) 0.0 (-0.01%) 0.0 (0.0%) 0.0 (-0.06%) 0.01 (3.89%) 0.01 (2.82%) 0.0 (0.0%) 0.01 (2.13%)

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.12
Diluted EPS:
-0.12
Basic P/E:
-2.7967
Diluted P/E:
-2.7967
RSI(14) 1m:
91.84
VWAP:
0.34
RVol:

Events

Period Kind Movement Occurred At

Related News